Autologous DC vaccine

BIOLOGICAL2 trials

Sponsors

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Conditions

Carcinoma, Renal CellHead Neck TumorsNeuroendocrine TumorsRare CancerSecondarySoft Tissue SarcomaVaccination

Phase 2

Vaccination With Dendritic Cells Pulsed With Autologous Tumor Homogenate in Combination With HD-IL2 and Immunomodulating Radiotherapy in Metastatic RCC

WithdrawnNCT03226236

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSCarcinoma, Renal Cell, Secondary, Vaccination

Start: 2016-03-31End: 2019-03-31Updated: 2018-11-13

A Phase II Study on Adjuvant Vaccination with Dendritic Cells Loaded with Autologous Tumor Homogenate in Resected Stage IV Rare Cancers.

RecruitingNCT04166006

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSHead Neck Tumors, Neuroendocrine Tumors, Rare Cancer +2

Start: 2019-12-12End: 2031-12-31Target: 51Updated: 2024-09-19